Elevated expression of the leukemia-associated antigen SSX2IP predicts survival in acute myeloid leukemia patients who lack detectable cytogenetic rearrangements

Blood. 2009 Jan 29;113(5):1203-4. doi: 10.1182/blood-2008-09-178848.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Antigens, Neoplasm / genetics*
  • Antigens, Neoplasm / immunology
  • COS Cells
  • Chlorocebus aethiops
  • Disease-Free Survival
  • Epitopes / genetics*
  • Epitopes / immunology
  • Female
  • Gene Expression Regulation, Leukemic / genetics
  • Gene Expression Regulation, Leukemic / immunology
  • HL-60 Cells
  • Humans
  • Immunotherapy / methods
  • K562 Cells
  • Leukemia, Myeloid, Acute / genetics*
  • Leukemia, Myeloid, Acute / immunology
  • Leukemia, Myeloid, Acute / pathology
  • Leukemia, Myeloid, Acute / therapy
  • Male
  • Peptides / genetics*
  • Peptides / immunology
  • Prognosis
  • RNA, Neoplasm / genetics
  • RNA, Neoplasm / immunology
  • Survival Rate

Substances

  • Antigens, Neoplasm
  • Epitopes
  • Peptides
  • RNA, Neoplasm